9,515€
-1,30%
Echtzeit-Aktienkurs ASTELLAS PHARMA INC.
Bid:
Ask:
Echtzeit-Chart der ASTELLAS PHARMA INC. Aktie
Börsenkurse ASTELLAS PHARMA INC.
Börse Stuttgart | - | - | - | - | 9,662€ | 0,52% |
Tradegate | - | - | - | - | 9,509€ | -1,69% |
Lang & Schwarz | - | - | - | - | 9,515€ | -1,30% |
Echtzeit Euro | - | - | - | - | 9,682€ | -0,66% |
Börse Frankfurt | - | - | - | - | 9,434€ | 0,98% |
gettex | - | - | - | - | 9,607€ | -1,34% |
Profil der ASTELLAS PHARMA INC. Aktie
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.